Past Workshops & Publications 2011-2010

Benefit-Risk

2011-2010 | 2009-2008 | 2007-2005 | 2004-2002

YEAR DESCRIPTION DOWNLOADS AND PUBLICATIONS  
2011

Evolving the Regulatory Review Process What are the features which enable a transparent, timely, predictable and good quality review; Kuala Lumpur, Malaysia: 6-7 December 2011

Workshop Programme PDF

Workshop Snopsis PDF

 

Understanding HTA and coverage               decision-making processes: The key to facilitating transparent access to medicines; Surrey, UK: 28-29 September 2011

Workshop Programme PDF

Workshop Synopsis PDF

 

Visualising Benefit-Risk: The key to developing a framework that informs stakeholder perspective and clarity of decision making; Washington, DC, US: 16-17 June 2011

Workshop Programme PDF

Workshop Synopsis PDF

 

Evidentiary requirements in clinical development: Synchronising phase III requirements to meet multiple needs; Geneva, Switzerland: 31 March-1 April 2011

Workshop Programme PDF

Workshop Synopsis PDF

 

Regional Alignment in Asia Pacific: What needs to be in the regulatory science "toolkit" to enable good regulatory decision making; Tokyo, Japan: 26-27 January 2011

Workshop Programme PDF

Workshop Synopsis PDF

Workshop Report

2010 New development paradigms:  Building regulatory confidence for the early release of medicines; Surrey, UK:  11-12 October 2010

Workshop Programme PDF

Workshop Synopsis PDF

Workshop Report PDF

  Refining the benefit-risk framework for the assessment of medicines: Valuing and weighting benefit and risk parameters; Washington, DC, US: 17-18 June 2010

Workshop Programme PDF

Workshop Report      Liberti L, Walker S, McAuslane N, Connelly P. Strategies for communicating benefits and risks to decision-makers: Explaining methods, findings and conclusions through a common language approach. Workshop Report, CMR International Institute for Regulatory Science. June 2010.

Related Publication     Walker S, Liberti L, McAuslane N. Refining the benefit-risk framework for the assessment of medicines: valuing and weighting benefit and risk parameters. Clin Pharmacol Ther. 2011 89:179-82.

  Review and Reimbursement: Aligning the needs and requirements in clinical development; Washington, DC, US: 23 - 24 March 2010

Workshop Programme PDF

Workshop Report          Pichler, F, Liberti L, Connelly P. Review and reimbursement: Aligning the needs and requirements in clinical development. Workshop Report, CMR International Institute for Regulatory Science. March 2010.

2011-2010 | 2009-2008 | 2007-2005 | 2004-2002